Free Republic

A little pill called Captagon turns Jihadists into superhuman soldiers. They dont feel pain, they dont fear death and they dont get tired. They become killing machines. Bonus; it makes them murderously psychotic and causes brain damage after prolonged use. It is cheap, easy to produce and highly addictive. The Syrians take it as do the rebels. And from what I hear, ISIS loves the stuff. They laugh when they are beaten, they are high when they rape, they are jazzed when they behead infidels. During the raid in Paris, French police said they found needles used by the attackers...

Natalie Boyce was a “fit and healthy” student who dreamt of travelling the world and buying her own home. The 21-year-old from Rowville in Melbourne’s southeast — a competitive netball player and hardworking student in her fourth year of law and commerce at Deakin University — would have turned 22 on Monday. Nearly one year ago, on March 27, 2022 — her late grandmother’s birthday — Natalie died of heart failure at The Alfred Hospital, six weeks after receiving a booster dose of the Moderna vaccine. “You’ll never be the same,” her mother Deborah Hamilton, 52, told news.com.au. “No parent...

Researchers from Japan reveal that they may just have found a way to repair cardiac damage in patients suffering from chronic heart attack and heart failure. Adult heart cells have very limited ability to form new heart tissue, so when the heart muscle is damaged by a heart attack, the damaged areas are filled in with inflexible scar tissue. The presence of scar tissue impairs heart function and leads to arrhythmias, progressive heart failure and eventual death. "Previous studies have shown that reprogramming cardiac fibroblasts (CFs), the cell type that generates scar tissue, into cardiomyocytes (CMs), or normal heart muscle...

Democratic Rep. Sean Casten's 17-year-old daughter Gwen passed away earlier this year due to sudden cardiac arrythmia, the family noted in a statement. "In layman's terms, she was fine, and then her heart stopped," the statement explained, noting that the young woman was healthy and that the family does not know the reason the heart issue occurred. "Gwen was a healthy 2022 teenager. She ate well, exercised, got regular check-ups, didn't suffer from any behavioral health issues, and had close relationships with family and friends. She was fully vaccinated, and quarantined after occasional positive, asymptomatic COVID tests during the omicron...

The anti-inflammatory benefits of a common gout medicine may help save the lives of heart failure patients, researchers say. The medication, colchicine, could also reduce the risk of heart attack and stroke in patients whose arteries are clogged with cholesterol, according to the study authors. "The signal for benefit with colchicine in these patients was very impressive, and I expect that these findings will have quite a significant impact on clinical care in heart failure and future research for patients with this condition," Dr. Kenneth Bilchick said. He's a professor of cardiovascular medicine. For the study, Bilchick and his team...

A review published in the Journal of Internal Medicine provides convincing evidence that micronutrients—including iron, selenium, zinc, copper, and coenzyme Q10—can impact the function of cardiac cells' energy-producing mitochondria to contribute to heart failure. The findings suggest that micronutrient supplementation could represent an effective treatment for heart failure. "Micronutrient deficiency has a high impact on mitochondrial energy production and should be considered an additional factor in the heart failure equation, moving our view of the failing heart away from "an engine out of fuel" to "a defective engine on a path to self-destruction," said co–lead author Nils Bomer, Ph.D., of...

On December 14th, 2021, Nature Medicine released a study based on a broad population data set analyzed by researchers at Oxford University. The researchers examined the risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination and infection. The Oxford researchers reveal that 1 in 100 or 1% of all vaccinated individuals were admitted to the hospital or died with arrhythmia or irregular heartbeat. On December 14th, 2021, Nature Medicine released a study based on a broad population data set analyzed by researchers at Oxford University. The researchers examined the risks of myocarditis, pericarditis, and cardiac arrhythmias associated with...

A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionize treatment. Early research had shown that Sodium-glucose co-transporter-2 (SGLT2) inhibitors could help around half of heart failure patients—those with a condition known as reduction ejection fraction. But new findings published today show that the medication could be beneficial for all heart failure patients—including those with a second type of heart failure called preserved ejection fraction. It is the first drug to provide a real benefit in terms of improving outcomes for these patients. And the research team say it will...

Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. Predisposing factors included smoking, obesity, high blood pressure, high cholesterol, diabetes, and cardiovascular disease. "This is the first study to report that among individuals with a least one risk factor for heart failure, those taking aspirin were more likely to subsequently develop the condition than those not using the medication," said study author Dr. Blerim Muja. The influence of aspirin on heart failure is controversial. This study aimed to evaluate its relationship with heart failure incidence in...

Though separate cohort found even higher risk with COVID infection.. The Pfizer COVID-19 mRNA vaccine was found to be associated with a threefold increased risk of myocarditis, according to a real-world case-control study from Israel. Vaccination had a strong association with an increased risk of myocarditis (risk ratio [RR] 3.24, 95% CI 1.55-12.44), as well as increased risks of lymphadenopathy (RR 2.43, 95% CI 2.05-2.78), appendicitis (RR 1.40, 95% CI 1.02-2.01), and herpes zoster infection (RR 1.43, 95% CI 1.20-1.73), reported Ran Balicer, MD, of Clalit Health Services in Tel Aviv, and colleagues. However, in a separate cohort, infection with...

Canadian doctor Charles Hoffe believes that the mRNA vaccines manufacture microscopic blood clots in the capillaries of the vaccinated and at least 60 percent could eventually succumb to heart failure. Charles Hoffe, who practices medicine at Lytton British Columbia, explained: “We now know that only 25 percent of the ‘vaccine’ injected into a person’s arm actually stays in your arm. The other 75 percent is collected by your lymphatic system and literally fed into your circulation so these little packages of messenger RNA, and by the way in a single dose of Moderna ‘vaccine’ there are literally 40 trillion mRNA...

Dr Charles Hoffe MD, in his latest update of July 6, 2021 is reporting on the disturbing findings in his patients. He says the mRNA vaccines are plugging up thousands of tiny capillaries in the blood of those who took the ‘vaccine.’ Most will die in a few short years from heart failure. The spike proteins injected, which are designed to be mass produced in the bodies of the vaccinated, are the cause of the clotting, which is having adverse effects on no fewer than 60 percent of people injected. Dr Hoffe, who practices medicine at Lytton BC Canada explains:...

Myocarditis after mRNA COVID-19 vaccination is a rare adverse event that often resolves quickly, without treatment. ================================================================================ Shirley Graves had a rare adverse event, inflammation of the heart, after receiving her first COVID-19 shot. PHOTO BY TONY CALDWELL /Postmedia =============================================================================== On March 11, Shirley Graves did what she does every day — walked to the barn to do chores. But this was no ordinary morning. By the time she got there, she had a burning pain in her chest and was sweating profusely. The retired nurse was convinced she was having a heart attack. Fearing she was “going down,” Graves...

MONDAY, April 4, 2016 -- Regular doses of vitamin D3 may improve heart function in heart failure patients, a new British study suggests. "These findings could make a significant difference to the care of heart failure patients," said study leader Dr. Klaus Witte, from the University of Leeds School of Medicine. "It is the first evidence that vitamin D3 can improve heart function of people with heart muscle weakness -- known as heart failure."

Pills used to treat depression also help mend ailing hearts, a study has found. Seroxat, a widely-used anti-depressant, worked ‘far better’ than the standard treatment for heart failure. The so-called happy pills not only stopped the heart from deteriorating further – they actually helped mend it.

The technique, which involves a simple injection, could aid the recovery of hundreds of thousands of heart failure patients - and could even consign heart transplants to history. Researchers hope to increase levels of SERCA2a, a protein in heart muscle cells that plays an important role in heart muscle contraction The technique, which involves a simple injection, could aid the recovery of hundreds of thousands of heart failure patients. Heart transplants could even be consigned to history thanks to a trial by Imperial College, London, which aims to show for the first time that gene therapy could repair failing organs....

First-in-humans study introduces next generation cell therapyROCHESTER, Minn. — Translating a Mayo Clinic stem-cell discovery, an international team has demonstrated that therapy with cardiopoietic (cardiogenically-instructed) or "smart" stem cells can improve heart health for people suffering from heart failure. This is the first application in patients of lineage-guided stem cells for targeted regeneration of a failing organ, paving the way to development of next generation regenerative medicine solutions. Results of the clinical trial appear online of the Journal of the American College of Cardiology. VIDEO ALERT: Audio and video resources are available on the Mayo Clinic News Network. The multi-center,...

Fox News reports: A provision of ObamaCare is set to punish roughly two-thirds of U.S. hospitals evaluated by Medicare starting this fall over high readmission rates Starting in October, Medicare will reduce reimbursements to hospitals with high 30-day readmission rates “Among patients with heart failure, hospitals that have higher readmission rates actually have lower mortality rates,” said Sunil Kripalani, MD, a professor with Vanderbilt University Medical Center who studies hospital readmissions. “So, which would we rather have — a hospital readmission or a death?”If this is really true, then it’s quite scary. I googled the doctor’s quote to try to...

Low levels of vitamin C were associated with higher levels of high sensitivity C-Reactive protein (hsCRP) and shorter intervals without major cardiac issues or death for heart failure patients, in research presented at the American Heart Association's Scientific Sessions 2011. Compared to those with high vitamin C intake from food, heart failure patients in the study who had low vitamin C intake were 2.4 times more likely to have higher levels of hsCRP, a marker for inflammation and a risk factor for heart disease. The study is the first to demonstrate that low vitamin C intake is associated with worse...

Vitals Major Finding: Eplerenone reduced the risk of cardiovascular death or heart failure hospitalization by 37%, compared with placebo. Data Source: Phase III randomized trial in 2,737 patients with NYHA class II heart failure. Disclosures: EMPHASIS-HF was funded by Pfizer. Dr. Zannad reported receiving grants from and consulting for Pfizer. Two coauthors are Pfizer employees, and several others reported Pfizer grants and consultancy. CHICAGO — Adding eplerenone to standard therapy significantly cut the risk of cardiovascular death and heart failure hospitalization by more than one-third in patients with mild heart failure in the phase III EMPHASIS-HF trial. The primary composite...